Verification Is the New Clinical Skill — A Guest Post by Lucian Feraru, DPM #AIinMedicine #ClinicalAI

A guest essay by Dr. Lucian Feraru. As ambient scribes and AI engines learn to write the note, summarize the chart, and flag the risk, the physician's job quietly changes — from author to auditor. Feraru argues the next real clinical skill is not generation but verification, and warns against a bargain in which the machine gets the speed, the doctor gets the liability, and the patient gets whatever slips through the gap.

0

Same Clinic Room, 27 Years Apart: Our Daughter Just Graduated Chief Resident Where It All Began #LimbPreservation #ActAgainstAmputation #ToeAndFlow #UTSA

Twenty-seven years ago I propped my two-year-old on an exam chair at the Texas Diabetes Institute. This week, in the same clinic room, same chair, same clock, she graduated chief resident, trained by my former fellow Lee Rogers, my research partner Larry Lavery, and the legendary Bob Frykberg. A note on three generations, the team approach, and the giants who raised my daughter into this profession.

2

Walk a Mile in Your Patient’s #Exoskeleton: Bidirectional #Robotics Rewires #Stroke Gait #Rehab @AbilityLab @NorthwesternU @SciRobotics

A new Science Robotics study from Northwestern and the Shirley Ryan AbilityLab virtually couples a therapist's and a stroke survivor's exoskeletons so they feel each other's movements in real time — turning "walk a mile in your patient's shoes" into an actual control law, with a clear path toward home-based, remote gait rehab.

0

The Census and the Core Sample: #STEADY, DARE-DiaFoot, and How We #MeasureWhatWeManage in the #DiabeticFoot

Two diabetic foot data engines published the same day on two continents. STEADY (US) is a 5,000-patient, AI-enabled real-world registry; DARE-DiaFoot (Italy) is a deep, multi-instrumental phenotyping protocol that quietly studies remission. One is the census, the other the core sample. Together with EURODIALE, the U.S. Wound Registry, and the National Diabetes Foot Care Audit, they sketch a blueprint for finally measuring what we manage.

0

Co-Creating the Foot Selfie– in Peru! A Patient-Centered App to Prevent Diabetic Foot Ulcers — Built With, Not For #FootSelfie #ActAgainstAmputation #DiabeticFoot #GlobalHealth @usc_vascular @alpslimb

A new paper in BMC Health Services Research describes how we co-created a Foot Selfie app with, not for, people living with diabetes, caregivers, and clinicians in urban Lima and semi-rural Piura, Peru. Here is how the end-users redesigned remote diabetic foot surveillance to fit the rooms where it actually happens.

0

A Toe-and-Flow Welcome in Dublin: Standing Room Only at The Beaumont Multidisciplinary #DiabeticFoot Symposium #ActAgainstAmputation

Notes from the Beaumont Multidisciplinary Diabetic Foot Symposium in Dublin (18 June 2026) — a true toe-and-flow gathering across vascular surgery, podiatry, endocrinology and infectious diseases, where the watchword was remission, not cure.

0

Old Drugs, New Logic: Could #Metformin Be a Causal Repair Switch in the #DiabeticFoot? A #microRNA + #DrugRepurposing #ActAgainstAmputation

A new multi-omics preprint uses Mendelian randomization to argue that six circulating miRNAs causally regulate peripheral artery disease in the diabetic foot—and flags metformin as the most translationally tractable repurposing candidate. A nice piece of computational scaffolding, with the usual in-silico caveats.

1

Zero Amputations. In One of the Toughest ZIP Codes in Diabetes America. #ActAgainstAmputation

Four years of data from MLK Community Healthcare show what happens when you build diabetic foot care around the patient — in exactly the place the map says amputations should be worst.

2

A Foot Ulcer Is a Whole-Body Diagnosis: New 5698 Patient Cohort Puts DFU Survival Back in the Cancer Conversation — But There’s Hope #DiabeticFoot #ActAgainstAmputation #ToeandFlow

A new 5,698-patient real-world cohort from Valladolid (Del Río-Solá et al., Adv Wound Care 2026) reports 61.8% five-year survival overall, falling to 32.1% after major amputation — and concludes the diabetic foot ulcer should be treated as a marker of advanced systemic disease, not an isolated wound. The newest entry in a fifteen-year line of evidence putting DFU mortality squarely in the cancer conversation.

1

$8 Back for Every $1: Earlier Access to #DiabeticFoot Care Is a Bargain #ActAgainstAmputation #CostEffectiveness @alpslimb

A new Queensland study from Son Nghiem, Pete Lazzarini, Lauren Ward and colleagues in Diabetic Medicine finds that investing in earlier access to diabetic foot services returns nearly $8 for every $1 spent — with lower costs, fewer hospitalisations, and better quality of life.

0

Up ↑

Verified by MonsterInsights